In tumour vessel xenografts, EPHB4 expression switches the vascularization program from sprouting angiogenesis to circumferential vessel growth, and reduces the permeability of the tumour vascular system via the activation of the angiopoietin-1/Tie2 system at the endothelium/pericyte interface. The gene discussed is EPHB4; the disease is neoplasm.